Topic Review
Pharmacological Activities of Nigella sativa
Nigella sativa (NS), also known as black cumin, is one of the plants used in traditional medicine the most. Many studies on the NS have shown that their therapeutic properties are attributed to the seed, oil, and secondary metabolites. This plant has been studied extensively and has many medical uses, such as anti-inflammatory. NS or its phytochemical compounds, such as thymoquinone, can cause cell apoptosis via oxidative stress, block efflux pumps, enhance membrane permeability, and exert potent biocidal effects. 
  • 137
  • 19 Dec 2023
Topic Review
Effects of Sacha Inchi on CVD Risk Factors
Plukenetia volubilis Linneo or Sacha Inchi (SI), a traditional natural remedy indigenous to Peru and Brazil, has garnered global attention due to its exceptional nutritional composition. Its protective effects against various non-communicable diseases, notably cardiovascular disease (CVD), have become a subject of interest in recent research. 
  • 173
  • 16 Nov 2023
Topic Review
Molecular Mechanisms of Berberine’s Neuroprotection
Berberine (BBR), an isoquinoline alkaloid natural product, is isolated primarily from Coptis chinensis and other Berberis plants. BBR possesses various bioactivities, including antioxidant, anti-inflammation, anticancer, immune-regulation, and antimicrobial activities. Growing scientific evidence underscores BBR’s substantial neuroprotective potential, prompting increased interest and scrutiny.
  • 148
  • 25 Oct 2023
Topic Review
Management of Hyperglycemia in Hospitalized Adult Patients
Hyperglycemia (blood glucose > 140 mg/dL or 7.8 mmol/L) in hospitalized patients without a history of diabetes is defined as stress hyperglycemia, and is reported in 32.2% of critically ill patients in intensive care units (ICUs) and 30% of noncritically ill hospitalized patients. Hyperglycemia alters immune response by inhibiting chemotaxis and phagocytosis. It affects the bactericidal ability of immune cells by decreasing the production of superoxide radicals. Hyperglycemia also induces osmotic diuresis, endothelial injury, and mitochondrial dysfunction, which can lead to shock and multiple organ failure in hospitalized patients.
  • 171
  • 18 Oct 2023
Topic Review
Obesity Treating Natural Products
Obesity is a global issue faced by many individuals worldwide. However, no drug has a pronounced effect with few side effects. Green tea, a well-known natural product, shows preventive effects against obesity by decreasing lipogenesis and increasing fat oxidation and antioxidant capacity. In contrast, other natural products are known to contribute to obesity. The natural products were classified as single compounds, foods, teas, fruits, herbal medicines—single extract, herbal medicines—decoction, and herbal medicines—external preparation. Then, the mechanisms of these medicines were organized into lipid metabolism, anti-inflammation, antioxidation, appetite loss, and thermogenesis. This research aimed to assess the efficacy and mechanisms of effective natural products in managing obesity. Several clinical studies reported that natural products showed antiobesity effects, including Coffea arabica (coffee), Camellia sinensis (green tea), Caulerpa racemosa (green algae), Allium sativum (garlic), combined Ephedra intermedia Schrenk, Thea sinensis L., and Atractylodes lancea DC extract (known as Gambisan), Ephedra sinica Stapf, Angelica Gigantis Radix, Atractylodis Rhizoma Alba, Coicis semen, Cinnamomi cortex, Paeoniae radixalba, and Glycyrrhiza uralensis (known as Euiiyin-tang formula).
  • 183
  • 27 Sep 2023
Topic Review
The Role of Intestinal Microbiome in Constipation
The gut microbiota represents a community of microorganisms (bacteria, fungi, archaea, viruses, and protozoa) that colonize the gut and are responsible for gut mucosal structural integrity and immune and metabolic homeostasis. The relationship between the gut microbiome and human health has been intensively researched in the past years. The gut microbial population plays a key role in intestinal motility, and dysbiosis has been correlated with chronic constipation.
  • 198
  • 22 Sep 2023
Topic Review
Effects of Nigella sativa on Obesity
Obesity has become a worldwide epidemic and its prevalence continues to increase at an alarming rate. It is considered a major risk factor for the development of several comorbidities, including type 2 diabetes, stroke, other cardiovascular diseases and even cancer. Conventional treatments for obesity, such as dietary interventions, exercise and pharmacotherapy, have proven to have limited effectiveness and are often associated with undesirable side effects. Therefore, there is a growing interest in exploring alternative therapeutic approaches. Nigella sativa (NS), a medicinal plant with multiple pharmacological properties, has gained attention due to its potential role in the treatment of obesity and its associated complications. 
  • 319
  • 20 Sep 2023
Topic Review
Framework for Training Parkinson Nurses
Delivering healthcare to people living with Parkinson’s disease (PD) may be challenging in face of changing care needs during a PD journey and a growing complexity. In this regard, integrative and personalized care models may foster flexible solutions to patients’ care needs whereas Parkinson Nurses (PN) may be pivotal facilitators. However, existing training frameworks do not include aspects of personalized care for PD although there is a great deal of literature on patient needs and the resulting care requirements. The conceptualization of a need-based training framework may thus be achieved by synthesizing theoretical concepts on care priorities from existing literature. Following, a novel framework for training PN is presented, which is based on a line of reasoning. In this approach, different hypotheses are formulated which then are integrated into a proposed model.
  • 497
  • 07 Sep 2023
Topic Review
Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases
Chronic inflammatory respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, present challenges in terms of effective treatment and management. These diseases are characterized by persistent inflammation in the airways, leading to structural changes and compromised lung function. To achieve optimal therapeutic outcomes while minimizing systemic side effects, targeted therapies and precise drug delivery systems are crucial to the management of these diseases.
  • 258
  • 31 Aug 2023
Topic Review
Thymosin α1
Thymosin α1 (Tα1) is an immunostimulatory peptide that is commonly used as an immune enhancer in viral infectious diseases such as hepatitis B, hepatitis C, and acquired immune deficiency syndrome (AIDS). Tα1 can influence the functions of immune cells, such as T cells, B cells, macrophages, and natural killer cells, by interacting with various Toll-like receptors (TLRs). Generally, Tα1 can bind to TLR3/4/9 and activate downstream IRF3 and NF-κB signal pathways, thus promoting the proliferation and activation of target immune cells.Moreover, TLR2 and TLR7 are also associated with Tα1. TLR2/NF-κB, TLR2/p38MAPK, or TLR7/MyD88 signaling pathways are activated by Tα1 to promote the production of various cytokines, thereby enhancing the innate and adaptive immune responses. At present, there are many reports on the clinical application and pharmacological research of Tα1, but there is no systematic review to analyze its exact clinical efficacy in these viral infectious diseases via its modulation of immune function.
  • 216
  • 29 Aug 2023
  • Page
  • of
  • 12